01+ &'$2(#/%3+$ *4('526'73+284+ 85)*79*3+ &'$2(#/%3+/: · 16 phases de...
TRANSCRIPT
!"#$%&#'(')#*+,-!.+*/+01+&'$2(#/%3+$’’*4"('526'73+284+
85)*79*3+&'$2(#/%3+/:%52"*86;8*3+29/8*((*3++!
"#!$%&'%()*!+,,+-"!./%#0*)((*1!234%5%67!89:8!
!
/,;<!
=+>;>!!•! ?*7@!%04*5&0!A!&'#36B30*!C*)D*70*!4#3E3D?*!.,<F1!*&!
*6B3()*!47(63D%)#*!.;F1G!(*!53D5*4&!?*!6%(%?)*!&'#36B3*6B3()H7*!C*)D*70*!./,;<1!
•! (’I4)?I6)3(3J)*!?*!(%!/,;<!#*0&*!#*(%KC*6*D&!6%(!53DD7*L!6%(%?)*!0)(*D5)*70*!)D0)?)*70*!!
•! M%!/,;<!*0&!7D!4#3B(N6*!6%O*7#!?*!0%D&I!47B()H7*!037C*D&!DIJ()JI!G!4#IC*DK3DP!
;FQ";/QRMRSQ;!
•! TI6*!5%70*!?*!63#&%()&IA!AQ"/U+<2U2+$2;-!!•! )D5)?*D5*!%DD7*((*!?*!(%!&'#36B30*!C*)D*70*!4#3E3D?*!*&!?*!(’*6B3()*!A!–!0*#%)&!?*!:V:999!*D!W#%D5*!
•! 8I6*!5%70*!?*!63#&%()&I!6%&*#D*((*!!•! :9!%!:XY!?*!(%!63#&%()&I!'304)&%()N#*!!•! 8I6*!5%70*!?*!#I'304)&%()0%K3D!!•! -5273<*532(#/%+$*++(2+"2/:'(')#*++!
,-,!F-RFZ[M+2,Q\];!
•! ?’7D*!4(70!J#%D?*!53663?)&I!?’*64(3)!V:!)DO*5K3D!4%#!O37#U!!
•! M’7K()&I!?*!(%!07#C*)((%D5*!#IJ7()N#*!?*!(%!D76I#%K3D!4(%H7*^%)#*!0370!Z=F/!D’%!4%0!I&I!?I63D&#I*!
•! ?*!(’%B0*D5*!?’%?%4&%K3D!?*0!?30*0!_!?*0!&*0&0!?’'I630&%0*!!
•! 7D*!#I?75K3D!?7!#)0H7*!'I63##%J)H7*!.Z=F/U!07#&37&!0370!E3D?%4%#)D7@1U!!
•! 7D*!#I?75K3D!?7!#)0H7*!?*!&'#36B34ID)*!)D?7)&*!.07#&37&!0370!E3D?%4%#)D7@1U!!!
=*3+>?@,+*/+(*+A'7$2"25#784+3'7/+"5%A%5%3+B+(’’>C0+DE52$*+?FG!
,-,!F-RFZ[M+2,Q\];!;$!/QMQ;]!2ZQ-]-SQ2+M!
F#3B%B)()&I!5()D)H7*!•! (’*0K6%K3D!?*!(%!4#3B%B)()&I!5()D)H7*!%`D!?*!?I&*#6)D*#!?%D0!
H7*(!J#374*!?*!4#IC%(*D5*!0*!0)&7*!(*!"26*7/+D"5'H2H#(#/%+A2#H(*G+&'$%5%*+'8+A'5/*F+,3#B)5a)!+U!.;>21L!;7#!Z*%#&!b!899c!d!8e!A!88fghi:XL!
•! 2*^*!4#IC%(*D5*!53##*043D?!_!(%!4#3B%B)()&I!?’%C3)#!%!4#)3#)!(%!6%(%?)*!?%D0!7D!J#374*!#*(%KC*6*D&!'363JND*!?*!6%(%?*0!
•! ;((*!4*7&!j&#*!*0K6I*!!–! 3'#/+$*+A2I'7+*&"#5#;8*!0*(3D!(*!&*##%)DU!(*0!E%5&*7#0!?*!
#)0H7*!U!(*0!5#)&N#*0!5()D)H7*0!–! 3'#/+B+(’’2#$*+$’’87+39'5*J+(*3+95#/K5*3+$*+E*7K<*+'8+$*+L*((3M++
053#*0!5()D)H7*0!
k(*!053#*!%!(’%C%D&%J*!?’j&#*!4(70!3BO*5KEU!4(70!#*4#3?75KB(*!*&!?*!437C3)#!0*#C)#!?*!#IEI#*D5*!437#!(*0!4(70!O*7D*0L!!k0*0!4*#E3#6%D5*0!03D&!63)D0!B3DD*0!5'*l!(*0!4*#03DD*0!mJI*0!*&!5'*l!(*0!4%K*D&0!%n%D&!?*0!%D&I5I?*D&0!&'#36B3*6B3()H7*0L!!k0%!C%(*7#!*0&!6I?)35#*!437#!(*0!&'#36B30*0!4#3E3D?*0!?)0&%(*0!!!
Antécédents d’EP ou de TVP : +1,5 FC > 100/min : +1,5 Chirurgie ou immobilisation récente : +1,5 Signes cliniques de TVP : +3 Diagnostic alternatif moins probable que celui d’EP : +3 Hémoptysie : +1 Cancer actif : +1 ------------------------------------------------------------------ faible : 0-1 intermédiaire : 2-6 forte : 7 ou plus 3 à 14 % 26 à 47 % 44 à 91 %
39'5*+$*+L*((3+$273++(’’!&H'(#*+@8(&'72#5*+++
Age > 65 ans : + 1 Antécedents de TVP et/ou EP : + 3 Chirurgie ou fracture / immob < 1 mois : + 2 Dysmitose évolutive : + 2 Douleur unilatérale mb inf : + 3 Hémoptysie : + 2 Pouls 75 – 94 / mn : + 3 Pouls > 95 / mn : + 5 OMI unilatéral et/ou cordon induré : + 4 ------------------------------------------------------------------ faible : 0 - 3 intermédiaire : 4 - 10 forte : 11 ou plus
39'5*+$*+E*7K<*+&'$#N%+$273+(’’!&H'(#*+@8(&'72#5*++
5 à 12 % 25 à 33 % 61 à 83 %
O9'5*+P(#7#;8*++*/++,2(2$#*+-:5'&H'Q!&H'(#;8*+.*#7*83*+:
+757D!?’*D&#*!D370U!H7*((*!H7*!03)&!03D!*@4I#)*D5*U!D*!4%#C)*D?#%!0*7(!_!5*^*!4#I5)0)3D!P!
;D!(*0!7K()0%D&U!34K6)0*#!(*0!0&#%&IJ)*0!*D!&*#6*!?*!#%443#&!BIDI`5*!#)0H7*!*&!?*!#*4#3?75KB)()&I!P!!
-3n!*&!%(L!"##!$#%&'#!(&)!899gd:TTA:XfhgT.
O/52/%)#*3+$#2)7'36;8*3+$*+(2+,-!.+!
O/52/%)#*3+$#2)7'36;8*3+$*+!@+!
16
Phases de la maladie
='7)+/*5&*+
Types des taitements anticoagulatnts Hnf,hbpm, fondaparinux FH, LMWH, fondaparinux
At least 5 days
&#%)&*6*D&!53DC*DK3DD*(!4%#!%DK53%J7(%D&0!
R7/*5&*$#2#5*++
R7#62(G+"25*7/*52(++/:*52"*869+$'3*++2769'2)8(26'7+
AVK INR 2.0–3.0 ou1.5–1.9
>3 months/ years/ indefinite*
='7)Q/*5&+&2#7/*7279*+276Q9'2)8(26'7S+3*9'7$25T+"5*<*76'7+
At least 3 months
AVK INR 2.0–3.0
!25(T+&2#7/*7279*S+3*9'7$25T+"5*<*76'7+
1#)8*++
*With re-assessment of the individual benefit–risk at periodic intervals KeKearon C, et al. Chest 2008;133;454–545; ESC Textbook of Cardiovascular Medicine 2nd Edition 2009. Chapter 37 Schellong S, Bounameaux H, Büller HR pp 1348–1349
-52#/*&*7/+98526A+$*+(2+,-!.+!
-U1R-!,!C-+V’’+!,?W=R!+@X=,WC1RU!+3/2H(*+:*&'$T72&#;8*&*7/+!
•! !"#$%&'($")$*"$+,-./0/12-34$#,-)$015+515#$6$*’’%78$9:1/."$;<$
•! (’+//!*0&!%553#?I*!%!(’ *7'42"25#7*!
•! ?IB7&*#!(*!&#%)&*6*D&A!–! !?N0!(%!5*#K&7?*!?)%JD30KH7*!–! 5%0!?*!E3#&*!4#3B%B)()&I!5()D)H7*.+553#?!4#3E*00)3DD*(1!
•! ,#%)&*6*D&!%6B7(%&3)#*!4%#!(*!E3D?%4%#)D7@!
U!=1RO+VX+-U1R-!,!C-+RCR-R1=!
•! 7D!#*(%)0!4%#!(*0!+<o!*0&!#*5366%D?I!.S#%?*!+1!?IB7&I!4#I535*6*D&!?N0!(*!:*#!O37#!?*!&#%)&*6*D&!4%#*D&I#%(!.S#%?*!+1L!
•! M’Z$WU!(’Z=F/!37!(*!E3D?%4%#)D7@!437##3D&!j&#*!%##j&I0!%7!B37&!?*!X!O37#0!_!53D?)K3D!H7*!?*7@!Q$-!53D0I57KE0!_!8T!'!?’)D&*#C%((*!03)*D&!074I#)*7#0!_!8!.S#%?*!=1L!
W+!
+!(’;2SU!•! (*0!3D?*0!F!0)D70%(*0!D*!03D&!4%0!C)0)B(*U!#*64(%5I*0!4%#!?*0!3D?*0!W!!
?3DD%D&!%!(%!()JD*!?*!B%0*!7D!%04*5&!&#I67(%D&L!!•! Q##IJ7(%#)&I!?*0!*04%5*0!--!
;FQ";/QRMRSQ;!•! (’%#n&'6)*!(%!4(70!E#IH7*D&*L!9LTY!_!:L:Y!?*!(%!4347(%K3D!JIDI#%(*!!•! F#IC)0)3DA!:!4*#03DD*!07#!T!?*!4(70!?*!T9!%D0!?IC*(344*#%!7D*!W+!•! 0%!4#IC%(*D5*!%7J6*D&*!%C*5!(’mJ*! !!
! !! ! !:Y!?*0!4*#03DD*0!mJI*0!?*!63)D0!!?*!g9!%D0!!!!!! !!!!!!!!!!!!!!!cY!?*!5*((*0!?*!4(70!?*!c9!%D0!
•! %7J6*D&*!*D!4#I0*D5*!?’7D*!)D07p0%D5*!5%#?)%H7*!*%!?*!C%(C7(34(%0K*0!
•! %0035)I*!%!7D*!%7J6*D&%K3D!?*!(%!63#&%()&I!?*!:LX!%!:LeY!?7*!%7@!!5364()5%K3D0!&'#36B3*6B3()H7*0!AX!E3)0!4(70!?*!#)0H7*!?q+<2!
•! -5'8H(*+$8+5T/:&*+(*+"(83+A5%;8*&&*7/+5*/5'8<%+28+O1X+DYZ+$*3+"26*7/3+2$F+
•! +[YZ+$*3+01+3'7/+$%9'8<*5/*3+28+O1X+•! !\MYZ+$*3+01+3'7/+$#2)7'36;8%*3+*7+O,XU+
-*J)0&#*!-;+MQ>;!+W!!I&7?*!89:9!•! :9!999!4%K*D&0!U8g!4%n0!4%#K5)4%D&0!!•! -*5#7&*6*D&!?*!4%K*D&0!%n%D&!7D!%&5?!?*!W+!!
?%D0!(*0!:8!63)0!4#I5I?*D&0!!•! 23D5(70)3D0!A!
–! F(70!?*!T9Y!037r#*!?’7D*!W+!D3D!53D&#s(I*!!–! ffY!3D&!7D*!23!63#B)?)&I!.?I5364*D0%K3D!
5%#?)%H7*!%DJ3#U!%C5!1!–! M%!6%O3#)&I!?*0!4%K*D&0!#*0&*!0n64&36%KH7*!6%(J#I!
(*0!&#%)&*6*D&0!!–! =*85+"5#3*+*7+9:25)*+*3/+7'7+9'7A'5&*+284+5*9'&&27$26'73+]]]]+
;<+M]+,QR$!2MQ$Q\];!•! M%!4#I0*D5*!*&!(%!D%&7#*!?*0!0n64&s6*0A!
4%(4)&%K3D0U!?37(*7#!&'3#%5)H7*U!?n04DI*U!E%KJ7*U!0nD534*!!
•! t&%B()#!(*!636*D&!?7!?IB7&!?*!(qI4)03?*!.)D&*#*&!?7!/-h4#3+$F1!u!37!v!Tc!'*7#*0!
•! ,3(*#%D5*!!•! -*5'*#5'*#!7D!ICID*6*D&!&'#36B3*6B3()H7*A!
+<2!4*7&!j&#*!4%#E3)0!(%!:*#*!6%D)E*0&%K3D!•! ]D*!5%70*!*@&#%!5%#?)%H7*w!
M;>!;xFMR-+,QR$>!!
•! ;2S!!•! =)(%D!B)3(3J)H7*!AI(*5(n&*0U!E3D5K3D!#ID%(*U!,>Z!
•! ;,,A!!–!7D*!6%(%?)*!C%(C7(%)#*w!–! (%!&%)((*!?*0!3#*)((*^*0!–! E#%5K3D!?’IO*5K3D!?7!<S!–!6*07#*#!(%!4#*00)3D!47(63D%)#*!.Z,+F1!
2M+>>QWQ2+,QR$!
>,-+,;SQ;!";!F-Q>;!;$!2Z+-S;!
>53#*!2Z+"><+>2!O/526N926'7+$8+5#3;8*+*&H'(#;8*+
>2R-;!Z+>h=M;"!!!•! y!M*!#)0H7*!?*!0%)JD*6*D&!?3)&!IJ%(*6*D&!j&#*!
IC%(7I!*&!?3)&!E%)#*!4%#K*!?*!&37&*!0&#%&IJ)*!&'I#%4*7KH7*!?%D0!(%!W+!z!%!)D0)0&I!(*!F#!2%66L!
M)6)&*0!?*0!+<o!
•! W*Dj&#*!&'I#%4*7KH7*!I)&*!Q$-!*D&#*!8!*&!iA!–!+7!?*(_!?*!i!#)0H7*!'I63##%J)H7*!–!+7!?*00370!?*!8!#)0H7*!?*!#I5)?)C*!&'#36B3*6B3()H7*!!!
•! S#%D?*!C%#)%B)()&I!?*!#I43D0*!!)D&*#!*&!)D&#%!6%(%?*0!.)D&*#%5K3D0!6I?)5%6*D&*70*0!%()6*D&%)#*0!1!
•! >7#C*)((%D5*!I)&*!!!
$37C*%7@!%DK53%J7(%D&0!3#%7@!!
•! 2)B(*D&!7D!E%5&*7#!?*!53%J7(%K3D!7D)H7*!!•! M%#J*!E*Dj&#*!&'I#%4*7KH7*!!•! +757D*!3B()J%K3D!?*!07#C*)((%D5*!!•! ]K()0%K3D!%!?30*0!`@*0!!•! F*7!?’)D&*#%5K3D!%C*5!(*0!%()6*D&0!37!(*0!
6I?)5%6*D&0!•! 6*)((*7#*!!*p5%5)&I!U6*)((*7#*!0I57#)&I!!•! /*)((*7#*!H7%()&I!?*!C)*!437#!(*0!6%(%?*0!*&!
6*)((*7#*!3B0*#C%D5*!!
=%7*#!o+L!89:9d!,7#4)*!+SL!899fd!{*)&l!bQL!89:9!
